DIANEONATAL

About Diagenics

Diagenics is a diagnostics company leveraging a proprietary biomarker platform to create rapid tests for emergency and critical care settings. Its product portfolio targets large markets in gynecology (preeclampsia), neurology (stroke), and cardiology (heart attack), with an additional commercial line in virology (COVID-19 antigen tests). Founded in 2005 and headquartered in Luxembourg with operational offices in Germany, the company positions itself as a pioneer in improving diagnostic speed and accuracy to influence patient outcomes.

Therapeutic Areas

Other Preeclampsia Drugs